Dr Lutz Jermutus

Dr Lutz Jermutus
Dr Lutz Jermutus
Senior Director, R&D

Profile of Dr Lutz Jermutus

Lutz Jermutus is a Product Development Team Leader and Senior Director, R&D, in MedImmune’s Cardiovascular & Metabolic Diseases iMED, responsible for leading clinical candidates from late stage pre-clinical through IND to clinical proof-of-concept. He was previously the global head of technology overseeing teams in the UK and US. In this role, he was leading non-antibody biologics technologies and resulting drug projects across all disease areas. Key activities included therapeutic peptides and proteins but also novel biologics modalities such as multiselective antibodies, polyclonal antibodies, antibody-drug-conjugates, scaffolds and oligonucleotides. His team established a phenotypic selection and screening platform that delivered novel therapeutic targets across all disease areas and managed multiple technology collaborations with biotechs including Evotec, Direvo Biotech, PeptiDream, Molecular Partners, Silence Therapeutics, Xenome and Retrogenix. Previously at Cambridge Antibody Technology, Lutz was director of discovery, oncology, and director of protein engineering.


Frances Neal
Scientist 1


Please login to send a Private Message

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021